Early and late complications of totally implantable venous access devices
- 1 May 1990
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 44 (1) , 52-54
- https://doi.org/10.1002/jso.2930440112
Abstract
We reviewed the records of 66 consecutive patients who underwent placement of totally implantable venous access devices (TIVADs). Fourteen patients (21%) experienced complications related to the TIVAD. Complications included hematoma, infection, pneumothorax, subclavian vein thrombosis, and chronic clavicular pain. The 1 month mortality rate following insertion of a TIVAD was 24% (16 of 66 patients); however, none of the patients died as a direct consequence of port insertion or its associated complications. Overall patient and physician acceptance of TIVADs was good, and we encourage continued use and study of this device.Keywords
This publication has 5 references indexed in Scilit:
- Reliability of Implantable Central Venous Access Devices in Patients With CancerArchives of Surgery, 1987
- Technique for placement of an implantable venous access systemThe American Journal of Surgery, 1986
- Implantable venous access devices: An alternative method of extended cancer careJournal of Surgical Oncology, 1986
- Implantable central venous access systemThe American Journal of Surgery, 1984
- MODIFIED RIGHT ATRIAL CATHETER FOR ACCESS TO THE VENOUS SYSTEM IN MARROW TRANSPLANT RECIPIENTS1979